Genetic variation in GLCCI1 and dexamethasone in bacterial meningitis

Journal of Infection

Volumn 65, Issue 5, 2012, Pages 465-467

  Brouwer, Matthijs C ^a   van der Ende, Arie ^a   Baas, Frank ^a   van de Beek, Diederik ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID;

APOPTOSIS; BACTERIAL MENINGITIS; CEREBROSPINAL FLUID CULTURE; CONTROLLED STUDY; DRUG EFFICACY; GENE; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GLUCOCORTICOID INDUCED TRANSCRIPT 1 GENE; HUMAN; IMMUNOCOMPETENT CELL; LETTER; LUNG ALVEOLUS CELL; MAJOR CLINICAL STUDY; NEISSERIA MENINGITIDIS; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; STREPTOCOCCUS PNEUMONIAE; TREATMENT OUTCOME;

ANTI-INFLAMMATORY AGENTS; COMMUNITY-ACQUIRED INFECTIONS; DEXAMETHASONE; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; KAPLAN-MEIER ESTIMATE; MENINGITIS, BACTERIAL; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; RECEPTORS, GLUCOCORTICOID;

EID: 84867329224     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2012.07.001     Document Type: Letter

References (8)

1. Tantisira K.G., Lasky-Su J., Harada M., Murphy A., Litonjua A.A., Himes B.E., et al. Genomewide association between GLCCI1 and response to glucocorticoid therapy in asthma. N Engl J Med 2011, 365(13):1173-1183.
2. Koedel U., Frankenberg T., Kirschnek S., Obermaier B., Häcker H., Paul R., et al. Apoptosis is essential for neutrophil functional shutdown and determines tissue damage in experimental pneumococcal meningitis. PLoS Pathog 2009, 5(5):e1000461.
3. Woehrl B., Brouwer M.C., Murr C., Heckenberg S.G., Baas F., Pfister H.W., et al. Complement component 5 contributes to poor disease outcome in humans and mice with pneumococcal meningitis. J Clin Invest 2011, 121(10):3943-3953.
4. Mook-Kanamori B.B., Geldhoff M., van der Poll T., van de Beek D. Pathogenesis and pathophysiology of pneumococcal meningitis. Clin Microbiol Rev 2011, 24(3):557-591.
5. Brouwer M.C., McIntyre P., de Gans J., Prasad K., van de Beek D. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev 2010, 9:CD004405.
6. van de Beek D., Farrar J.J., de Gans J., Mai N.T., Molyneux E.M., Peltola H., et al. Adjunctive dexamethasone in bacterial meningitis: a meta-analysis of individual patient data. Lancet Neurol 2010, 9(3):254-263.
7. Brouwer M.C., de Gans J., Heckenberg S.G., Zwinderman A.H., van der Poll T., van de Beek D. Host genetic susceptibility to pneumococcal and meningococcal disease: a systematic review and meta-analysis. Lancet Infect Dis 2009, 9(1):31-44.
8. Brouwer M.C., Heckenberg S.G., de Gans J., Spanjaard L., Reitsma J.B., van de Beek D. Nationwide implementation of adjunctive dexamethasone therapy for pneumococcal meningitis. Neurology 2010, 75(17):1533-1539.